Georgia's Online Cancer Information Center

Are We Ready for the Moonshot?

6/22/2016, National Comprehensive Cancer Network

FORT WASHINGTON, PA — White House Cancer Task Force Executive Director Gregory Simon will join a broad array of stakeholders at the National Comprehensive Cancer Network® (NCCN®) Policy Summit: Emerging Issues and Opportunities in Health Information Technology to address the state of health information technology (HIT), including the role and readiness of HIT systems in implementing the National Cancer Moonshot Initiative. The summit will take place at The National Press Club in Washington, D.C. on Monday, June 27, 2016, from 8:30 AM – 3:30 PM. For press credentials, contact NCCN Communications Manager Katie Kiley Brown at

Clinical cancer care, related quality initiatives, and emerging coverage models for care continue to evolve; how ready is Health Information Technology (HIT) to support this shifting landscape and other advances, such as personalized medicine? Of issue include a lack of interoperability between systems, varying complexities of systems, and issues of proprietary interest limit the understanding and exchange of information across systems and stakeholders. Panelists will discuss these issues, their role in the cancer care continuum, how they interact with HIT systems, and ultimately how they are developing solutions necessary to move beyond meaningful to make gains in precision medicine and quality care.

This policy summit will gather the many stakeholders—clinicians, government and regulatory organizations, patient advocacy groups, pharma-biotech companies, providers, and HIT companies and vendors—who are crucial to understand the challenges and opportunities in utilizing HIT to improve cancer care.

Clifford Goodman, PhD, of The Lewin Group will moderate the summit, which will consist of short presentations followed by roundtable discussions with lively discourse and ample time for audience questions. An abbreviated agenda is below.

As developers of widely used NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) that set standards for cancer treatment in the United States and abroad, NCCN is invested in supporting the provision of high-quality, value-based cancer care. In addition to hosting this timely conversation about the emerging role of HIT, NCCN is committed to digitizing its products and ensuring their functionality across multiple HIT systems so that patients with cancer have access to appropriate care.


Welcome and Introductions
Robert W. Carlson, MD
Chief Executive Officer
National Comprehensive Cancer Network

Moving Beyond Meaningful Use
Alexandra Mugge, MPH 
Deputy Director, Division of Health Information Technology
Centers for Medicare & Medicaid Services 

Panel Discussion - HIT: Readiness to Support Alternative Payment Models and Reporting 
for Precision Medicine and Quality Care


  • Amy Abernethy, MD, PhD
    Flatiron Health
  • Jonathan Hirsch
  • Michael Kolodziej, MD
    Aetna, Inc.
  • Mia Levy, MD, PhD
    Vanderbilt-Ingram Cancer Center
  • Alexandra Mugge, MPH 
    Centers for Medicare & Medicaid Services
  • Marcus Neubauer, MD
    McKesson Specialty Health
  • Allen Roeseler
  • Bret Shillingstad, MD
    Epic Systems Corporation

Moonshot Initiative
Gregory C. Simon
Executive Director
White House Cancer Task Force

Panel Discussion – Moonshot Initiative & The Role of HIT


  • Anthony Coletta, MD, MBA
    Independence Blue Cross
  • Mia Levy, MD, PhD
    Vanderbilt-Ingram Cancer Center
  • Edith Mitchell, MD
    Sidney Kimmel Cancer Center at Jefferson
  • Michael Pellini, MD
    Foundation Medicine
  • Allen Roeseler
  • Gregory C. Simon 
    White House Cancer Task Force

Leveraging HIT to Improve Quality of Clinical Care 
Lincoln Nadauld, MD, PhD
Medical Director of Cancer Genomics 
Intermountain Healthcare 

Panel Discussion – Issues, Opportunities, and Patient Impact


  • Amy Abernethy, MD, PhD
    Flatiron Health
  • Stephen Edge, MD
    Roswell Park Cancer Institute
  • Joanne Buzaglo, PhD
    Cancer Support Community
  • Thomas Farrington 
    Prostate Health Education Network, Inc.  
  • Lincoln Nadauld, MD, PhD
    Intermountain Healthcare
  • Michael Pellini, MD
    Foundation Medicine
  • Kyu Rhee, MD
    IBM Corporation

Wrap-Up and Conclusions

For more information about the NCCN Oncology Policy Program and to register for the event,

iAgenda subject to change.


About the National Comprehensive Cancer Network

The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 27 of the world's leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers. The primary goal of all NCCN initiatives is to improve the quality, effectiveness, and efficiency of oncology practice so patients can live better lives. For more information, visit

The NCCN Member Institutions are:

  • Fred & Pamela Buffett Cancer Center
  • Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute
  • City of Hope Comprehensive Cancer Center
  • Dana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center
  • Duke Cancer Institute
  • Fox Chase Cancer Center
  • Huntsman Cancer Institute at the University of Utah
  • Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance
  • The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
  • Robert H. Lurie Comprehensive Cancer Center of Northwestern University
  • Mayo Clinic Cancer Center
  • Memorial Sloan Kettering Cancer Center
  • Moffitt Cancer Center
  • The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
  • Roswell Park Cancer Institute
  • Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
  • St. Jude Children's Research Hospital/The University of Tennessee Health Science Center
  • Stanford Cancer Institute
  • University of Alabama at Birmingham Comprehensive Cancer Center
  • UC San Diego Moores Cancer Center
  • UCSF Helen Diller Family Comprehensive Cancer Center
  • University of Colorado Cancer Center
  • University of Michigan Comprehensive Cancer Center
  • The University of Texas MD Anderson Cancer Center
  • University of Wisconsin Carbone Cancer Center
  • Vanderbilt-Ingram Cancer Center
  • Yale Cancer Center/Smilow Cancer Hospital


View More

Media, News & Events

Greetings of gratitude from our president and CEO

Lynn gives a message of thanks and a glimpse into what's to come in 2022.


Cancer Center opens in Braselton

“This new collaborative space puts our patients’ needs front and center by providing a more cohesive environment with access to both medical oncology/hematology and radiation oncology services within steps of each other,” says Charles Nash III, MD, FACP, medical director of NGMC’s Cancer Services and medical oncologist with Longstreet Clinic (and Georgia CORE Board member).


Subscribe to Our Newsletter

Our email newsletter allows you to get the most up-to-date information right in your Inbox.

Subscribe Now
Georgia CORE


Advancing Cancer Care through Partnerships and Innovation

Georgia CORE is a statewide nonprofit that leverages partnerships and innovation to attract more clinical trials, increase research, and promote education and early detection to improve cancer care for Georgians in rural, urban, and suburban communities across the state.